Growth Metrics

Idexx Laboratories (IDXX) Income from Continuing Operations (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Income from Continuing Operations data on record, last reported at 248188000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 14.82% year-over-year to 248188000.0; the TTM value through Dec 2025 reached 1059464000.0, up 19.33%, while the annual FY2025 figure was 1059464000.0, 19.33% up from the prior year.
  • Income from Continuing Operations reached 248188000.0 in Q4 2025 per IDXX's latest filing, down from 274610000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 293989000.0 in Q2 2025 and bottomed at 131979000.0 in Q2 2022.
  • Average Income from Continuing Operations over 5 years is 210815300.0, with a median of 208260000.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: tumbled 34.86% in 2022, then soared 69.9% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 162771000.0 in 2021, then increased by 5.8% to 172207000.0 in 2022, then rose by 12.96% to 194521000.0 in 2023, then increased by 11.12% to 216149000.0 in 2024, then rose by 14.82% to 248188000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 248188000.0 in Q4 2025, 274610000.0 in Q3 2025, and 293989000.0 in Q2 2025.